The word “hormones” has become a catch-all explanation in wellness culture for everything from mood changes and weight gain to skin problems and fatigue. While this reflects genuine underlying biology, it also creates confusion, as symptoms are attributed to “hormone imbalance” without meaningful specificity, and solutions are sold on that basis without meaningful evidence.
This article focuses on what the science actually shows about female hormonal health across the lifespan: how the major hormonal systems work, what disrupts them, and what interventions have a solid evidence base.
The Menstrual Cycle as a Vital Sign
The menstrual cycle is far more than a reproductive event. It is a sensitive indicator of overall physiological health. Disruptions including irregular cycles, very heavy or very light periods, absent periods, or severe premenstrual symptoms often reflect underlying health issues rather than being problems in isolation.
A normal cycle ranges from 21 to 35 days in length, with menstruation lasting 2 to 7 days. Cycle length can vary somewhat between individuals while still reflecting healthy function.
The key hormones driving the cycle include:
Estrogen rises during the follicular phase, stimulating endometrial growth and driving ovulation when it peaks. Estrogen also affects bone density, cardiovascular function, skin collagen production, mood regulation, and cognitive function.
Progesterone rises after ovulation during the luteal phase, preparing the endometrium for potential implantation and contributing to the thermal shift detectable in basal body temperature tracking. Low progesterone in the luteal phase is associated with spotting, short cycles, and premenstrual symptoms.
Testosterone (present in women at lower concentrations than in men but physiologically significant) influences libido, energy, muscle maintenance, and mood.
LH and FSH (luteinizing hormone and follicle-stimulating hormone) are the pituitary signals that drive ovulation and regulate estrogen and progesterone production.
Premenstrual Symptoms: What the Evidence Supports
Premenstrual syndrome (PMS) affects a significant proportion of women during the luteal phase. Premenstrual dysphoric disorder (PMDD) is a more severe form that substantially impairs daily function.
The biological mechanisms are not fully elucidated, but the prevailing evidence implicates sensitivity to normal hormonal fluctuations (rather than abnormally high or low hormone levels), with downstream effects on serotonin, GABA, and other neurotransmitter systems.
What the research supports for reducing premenstrual symptoms:
Calcium supplementation has the most consistent evidence base of any nutritional intervention for PMS, with multiple randomized controlled trials showing reductions in mood symptoms, cramps, and food cravings. Doses studied are typically around 1,000 to 1,200 mg per day.
Magnesium has demonstrated benefit in several trials for reducing bloating, mood changes, and headaches associated with the luteal phase.
Aerobic exercise consistently reduces PMS severity across studies. The mechanism involves endorphin release, serotonin modulation, and reduction of prostaglandin-mediated cramping.
Dietary modifications with some evidence include reducing refined sugar, caffeine, and alcohol during the luteal phase, and increasing complex carbohydrates (which support serotonin synthesis via tryptophan transport).
Vitex agnus-castus (chasteberry) has shown modest benefit in several trials for PMS, particularly for breast tenderness and mood symptoms, likely through dopaminergic mechanisms that reduce prolactin and modulate progesterone.
Thyroid Health and Its Intersection With Female Hormones
Thyroid disorders are significantly more common in women than in men, and thyroid dysfunction is among the most common causes of symptoms frequently attributed to “hormone imbalance”: fatigue, weight changes, hair loss, mood disturbances, and irregular cycles.
The thyroid gland produces T4 (thyroxine) and T3 (triiodothyronine), which regulate metabolism throughout the body. Thyroid function is modulated by TSH (thyroid-stimulating hormone) from the pituitary.
Hypothyroidism (underactive thyroid) produces symptoms including fatigue, weight gain, cold intolerance, constipation, brain fog, and hair thinning. Hashimoto’s thyroiditis, an autoimmune condition, is the most common cause in developed countries.
Hyperthyroidism (overactive thyroid) produces symptoms including weight loss, heart palpitations, anxiety, heat intolerance, and irregular periods. Graves’ disease is the most common autoimmune cause.
Estrogen influences thyroid hormone transport proteins, which is why thyroid function can shift with pregnancy, oral contraceptive use, and the menopause transition.
Standard TSH testing is the appropriate first-line screen. If TSH is abnormal, further evaluation of T4, T3, and thyroid antibodies provides additional diagnostic information. Many thyroid-related symptoms are non-specific, and diagnosis should be based on laboratory findings in conjunction with clinical assessment rather than symptoms alone.
Perimenopause and Menopause: The Transition in Evidence
Perimenopause — the transition to menopause — typically begins in the mid-to-late 40s and can last several years. It is characterized by declining and fluctuating estrogen levels, increasingly irregular cycles, and a range of symptoms that vary considerably between individuals.
Common perimenopausal symptoms include:
- Vasomotor symptoms (hot flashes, night sweats)
- Sleep disruption
- Mood changes including anxiety and depressed mood
- Vaginal dryness and genitourinary changes
- Cognitive changes (often described as brain fog)
- Changes in body composition, particularly increased visceral fat
- Accelerated bone density loss
Hormone therapy (HT) remains the most effective evidence-based treatment for vasomotor symptoms and has demonstrated benefits for bone density, genitourinary health, and quality of life. The evidence picture has become significantly clearer since the reanalysis of the Women’s Health Initiative data, which showed that risks associated with HT are more nuanced than initial reports suggested and are influenced substantially by age of initiation, type of hormones, and route of administration.
Current guidance from major menopause societies generally supports HT for healthy women under 60 or within 10 years of menopause onset who have moderate to severe symptoms, absent specific contraindications.
Non-hormonal options with meaningful evidence for vasomotor symptoms include certain antidepressants (SSRIs, SNRIs), gabapentin, and more recently fezolinetant (a neurokinin 3 receptor antagonist). These are relevant for women who cannot or prefer not to use hormonal therapy.
Lifestyle factors with evidence for symptom reduction include: regular aerobic exercise (particularly for mood and sleep), dietary patterns lower in refined carbohydrates and alcohol (which can worsen vasomotor symptoms), and stress management practices.
What “Hormone Balancing” Products Generally Cannot Do
A substantial category of supplements markets itself as supporting “hormone balance” using ingredients like DIM (diindolylmethane), maca, ashwagandha, and various botanical blends. The evidence for most of these is sparse to moderate at best, and the framing of “balancing hormones” rarely maps onto any specific, measurable physiological outcome.
This is not to say these ingredients are entirely without merit. Ashwagandha has demonstrated some evidence for cortisol reduction and may have modest effects on thyroid function. DIM influences estrogen metabolism pathways in ways that are biologically plausible but not well-characterized clinically. Maca has some evidence for perimenopausal symptom reduction.
But “hormone balancing” as a marketing category is largely undifferentiated. Before spending on supplements in this space, identifying the specific hormonal issue through blood work, and ideally working with a clinician, will produce far better outcomes than guessing.
Practical Next Steps
If you are experiencing symptoms that you suspect are hormonally related, a reasonable first approach includes:
- Track your cycle and symptoms for at least two to three months to identify patterns
- Request a hormonal panel from your physician including TSH, estrogen, progesterone (timed to your cycle if pre-menopausal), testosterone, LH, and FSH as appropriate
- Review lifestyle factors with the strongest evidence: sleep consistency, dietary protein and fiber, exercise, and stress management
- Approach supplements selectively, based on specific identified needs rather than general “hormone support” marketing
For more on the intersection of nutrition and hormonal health, and the evidence on specific conditions affecting women, explore the related articles on BioFlowBeauty.